BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29948557)

  • 1. Origins of Metaplasia in the Esophagus: Is This a GE Junction Stem Cell Disease?
    Sayin SI; Baumeister T; Wang TC; Quante M
    Dig Dis Sci; 2018 Aug; 63(8):2013-2021. PubMed ID: 29948557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
    Zhang W; Wang DH
    Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction.
    Thompson JJ; Zinsser KR; Enterline HT
    Hum Pathol; 1983 Jan; 14(1):42-61. PubMed ID: 6832749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.
    Conio M; Filiberti R; Blanchi S; Giacosa A
    Eur J Cancer Prev; 2001 Dec; 10(6):483-7. PubMed ID: 11916346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
    Pera M
    World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
    Morales CP; Spechler SJ
    Am J Gastroenterol; 2003 Apr; 98(4):759-62. PubMed ID: 12738452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance and etiology of intestinal metaplasia of the esophagogastric junction.
    Goldblum JR
    Ann Diagn Pathol; 2002 Feb; 6(1):67-73. PubMed ID: 11842382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction.
    Vyas M; Celli R; Singh M; Patel N; Aslanian HR; Boffa D; Deng Y; Ciarleglio MM; Laine L; Jain D
    Hum Pathol; 2020 Nov; 105():67-73. PubMed ID: 32941964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction.
    Tytgat GN; Van Sandick JW; Lanschot JJ; Obertop H
    World J Surg; 2003 Sep; 27(9):1021-5. PubMed ID: 12917755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
    Stein HJ; von Rahden BH; Höfler H; Siewert JR
    Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus: recent insights into pathogenesis and cellular ontogeny.
    Kapoor H; Agrawal DK; Mittal SK
    Transl Res; 2015 Jul; 166(1):28-40. PubMed ID: 25701368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
    Dzinic SH; Mahdi Z; Bernardo MM; Vranic S; Beydoun H; Nahra N; Alijagic A; Harajli D; Pang A; Saliganan DM; Rahman AM; Skenderi F; Hasanbegovic B; Dyson G; Beydoun R; Sheng S
    PLoS One; 2019; 14(4):e0215089. PubMed ID: 31002675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and Cells of Origin of Barrett's Esophagus.
    Que J; Garman KS; Souza RF; Spechler SJ
    Gastroenterology; 2019 Aug; 157(2):349-364.e1. PubMed ID: 31082367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
    Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal adenocarcinoma arising in Barrett esophagus.
    Zhang HY; Spechler SJ; Souza RF
    Cancer Lett; 2009 Mar; 275(2):170-7. PubMed ID: 18703277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Origins of Barrett's Esophagus: the Search Continues.
    Rhee H; Wang DH
    Curr Gastroenterol Rep; 2018 Sep; 20(11):51. PubMed ID: 30259225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.